Hematology
From the Journals
Cardiovascular problems already apparent in children with hemophilia A
...
News
FDA approves recombinant treatment for hemophilia A or B with inhibitors
The new treatment is made using milk from transgenic rabbits.
From the Journals
COVID-19: Adjusting practice in acute leukemia care
From the Journals
Blood test might detect multiple cancer types, study suggests
The test, which uses methylation patterns in plasma cell-free DNA, had specificity and sensitivity approaching those needed for population-based...
News from the FDA/CDC
FDA okays emergency use of convalescent plasma for seriously ill COVID-19 patients
“It’s crucial that data be captured for every patient so that we really understand what safety and effectiveness looks like on as close to a real-...
From the Journals
CLL and breast cancer differ in the expression of regulatory microRNAs
A particular microRNA was found to be associated with prevascular invasion.
Conference Coverage
Webinar confronts unique issues for the bleeding disorders community facing COVID-19
Patients in gene therapy trials and those with factor inhibitors are of particular concern.
From the Journals
Sickle cell patients with vitamin D deficiency prone to more ED visits, longer stays
Screening for vitamin D deficiency may show benefits, authors suggest.
From the Journals
Genetic testing helps avoid false hemoglobinopathy diagnoses in newborns
“We now perform simultaneous protein-based and genetic testing as our standard clinical practice.”
Conference Coverage
Fear drives activity changes in hemophilia patients
Conference Coverage
Deferiprone noninferior to deferoxamine for iron overload in SCD, rare anemias
An oral iron chelator granted accelerated approval for thalassemia is noninferior to deferoxamine for iron overload in patients with sickle cell...